• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line.人甲状腺乳头状癌细胞系中ret原癌基因异常转录本的存在。
Jpn J Cancer Res. 1989 Dec;80(12):1149-52. doi: 10.1111/j.1349-7006.1989.tb01645.x.
2
Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas.甲状腺乳头状癌中c-ret RNA的表达及可变剪接
Oncogene. 2001 Feb 15;20(7):885-92. doi: 10.1038/sj.onc.1204161.
3
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinoma.RET/PTC3的分子特征;人类甲状腺乳头状癌中RET原癌基因的一种新的重排形式
Oncogene. 1994 Feb;9(2):509-16.
4
Proto-RET is rearranged in the new human papillary thyroid cancer cell line PTC-1113A.原肌球蛋白受体激酶(Proto-RET)在新的人甲状腺乳头状癌细胞系PTC-1113A中发生重排。
Cancer Genet Cytogenet. 1996 Jul 1;89(1):14-20. doi: 10.1016/0165-4608(95)00317-7.
5
Lack of PTC gene (ret proto-oncogene rearrangement) in human thyroid tumors.人类甲状腺肿瘤中缺乏PTC基因(ret原癌基因重排)。
Endocrinol Jpn. 1991 Dec;38(6):627-32. doi: 10.1507/endocrj1954.38.627.
6
The ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas.原癌基因ret在人类嗜铬细胞瘤和甲状腺髓样癌中持续表达。
Oncogene. 1990 Oct;5(10):1595-8.
7
Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas.在甲状腺乳头状癌中鉴定RET原癌基因两种致癌重排形式的产物。
Oncogene. 1992 Nov;7(11):2189-94.
8
Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation.通过原位杂交检测人甲状腺乳头状癌中RET癌基因的激活
Br J Cancer. 1992 Dec;66(6):1094-8. doi: 10.1038/bjc.1992.416.
9
Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line.在人神经母细胞瘤细胞系中对编码两种蛋白产物异构体的原癌基因ret信使核糖核酸的特性分析。
Oncogene. 1990 Jan;5(1):97-102.
10
RET receptor expression in thyroid follicular epithelial cell-derived tumors.RET受体在甲状腺滤泡上皮细胞源性肿瘤中的表达。
Cancer Res. 2000 Jun 1;60(11):2845-9.

引用本文的文献

1
Selpercatinib combination with the mitochondria-targeted antioxidant MitoQ effectively suppresses RET-mutant thyroid cancer.塞尔帕替尼与线粒体靶向抗氧化剂MitoQ联合使用可有效抑制RET突变型甲状腺癌。
NPJ Precis Oncol. 2024 Feb 20;8(1):39. doi: 10.1038/s41698-024-00536-7.
2
Acute exposure to diesel particulate matter promotes collective cell migration in thyroid cancer cells.急性暴露于柴油颗粒物会促进甲状腺癌细胞的集体细胞迁移。
Front Toxicol. 2023 Nov 30;5:1294760. doi: 10.3389/ftox.2023.1294760. eCollection 2023.
3
RET signaling pathway and RET inhibitors in human cancer.人类癌症中的RET信号通路与RET抑制剂
Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022.
4
FAM83B is involved in thyroid cancer cell differentiation and migration.FAM83B 参与甲状腺癌细胞的分化和迁移。
Sci Rep. 2022 May 21;12(1):8608. doi: 10.1038/s41598-022-12553-2.
5
Inhibition of FGF receptor blocks adaptive resistance to RET inhibition in CCDC6-RET-rearranged thyroid cancer.FGFR 抑制可阻断 CCDC6-RET 重排甲状腺癌对 RET 抑制的适应性耐药。
J Exp Med. 2022 Jun 6;219(6). doi: 10.1084/jem.20210390. Epub 2022 May 5.
6
Analysis of NIS Plasma Membrane Interactors Discloses Key Regulation by a SRC/RAC1/PAK1/PIP5K/EZRIN Pathway with Potential Implications for Radioiodine Re-Sensitization Therapy in Thyroid Cancer.对NIS质膜相互作用分子的分析揭示了由SRC/RAC1/PAK1/PIP5K/埃兹蛋白通路进行的关键调控,这对甲状腺癌放射性碘再敏化治疗具有潜在意义。
Cancers (Basel). 2021 Oct 30;13(21):5460. doi: 10.3390/cancers13215460.
7
Systematic review of the receptor tyrosine kinase superfamily in neuroblastoma pathophysiology.系统评价神经母细胞瘤病理生理学中的受体酪氨酸激酶超家族。
Cancer Metastasis Rev. 2022 Mar;41(1):33-52. doi: 10.1007/s10555-021-10001-7. Epub 2021 Oct 30.
8
Selumetinib Activity in Thyroid Cancer Cells: Modulation of Sodium Iodide Symporter and Associated miRNAs.索拉非尼在甲状腺癌细胞中的活性:钠碘转运体及其相关 miRNA 的调节。
Int J Mol Sci. 2018 Jul 17;19(7):2077. doi: 10.3390/ijms19072077.
9
Epigenetic Modifications in Thyroid Cancer Cells Restore NIS and Radio-Iodine Uptake and Promote Cell Death.甲状腺癌细胞中的表观遗传修饰可恢复钠碘同向转运体(NIS)和放射性碘摄取,并促进细胞死亡。
J Clin Med. 2018 Mar 21;7(4):61. doi: 10.3390/jcm7040061.
10
Multi-Color Spectral Transcript Analysis (SPECTRA) for Phenotypic Characterization of Tumor Cells.多色光谱转录分析(SPECTRA)用于肿瘤细胞表型特征分析。
Biomolecules. 2013 Feb 11;3(1):180-97. doi: 10.3390/biom3010180.

本文引用的文献

1
A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.人类甲状腺乳头状癌及其淋巴结转移灶中的一种新致癌基因。
Nature. 1987;328(6126):170-2. doi: 10.1038/328170a0.
2
Expression of proto-ret mRNA in embryonic and adult rat tissues.
Biochem Biophys Res Commun. 1988 Jun 30;153(3):1290-5. doi: 10.1016/s0006-291x(88)81368-8.
3
Molecular cloning and characterization of human ret-II oncogene.人类ret-II癌基因的分子克隆与特性分析
Oncogene Res. 1988 Sep;3(2):193-7.
4
Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.编码具有两个潜在跨膜结构域的酪氨酸激酶的原癌基因ret的克隆与表达。
Oncogene. 1988 Nov;3(5):571-8.
5
ret transforming gene encodes a fusion protein homologous to tyrosine kinases.原癌基因编码一种与酪氨酸激酶同源的融合蛋白。
Mol Cell Biol. 1987 Apr;7(4):1378-85. doi: 10.1128/mcb.7.4.1378-1385.1987.
6
Activation of a novel human transforming gene, ret, by DNA rearrangement.通过DNA重排激活一种新型人类转化基因ret
Cell. 1985 Sep;42(2):581-8. doi: 10.1016/0092-8674(85)90115-1.
7
Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage.通过连锁分析将2A型多发性内分泌腺瘤定位到10号染色体。
Nature. 1987;328(6130):528-30. doi: 10.1038/328528a0.
8
A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10.10号染色体上与2A型多发性内分泌腺瘤相关的遗传标记
Nature. 1987;328(6130):527-8. doi: 10.1038/328527a0.
9
Establishment and biological characterization of an in vitro human cytomegalovirus latency model.体外人巨细胞病毒潜伏模型的建立及生物学特性研究
Virology. 1987 Nov;161(1):62-72. doi: 10.1016/0042-6822(87)90171-1.
10
Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing.ret-II癌基因的激活,该基因没有编码跨膜结构域的序列,以及由于可变剪接导致羧基末端不同的两种ret-II癌基因产物的转化活性。
Oncogene. 1989 Jun;4(6):789-94.

人甲状腺乳头状癌细胞系中ret原癌基因异常转录本的存在。

Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line.

作者信息

Ishizaka Y, Itoh F, Tahira T, Ikeda I, Ogura T, Sugimura T, Nagao M

机构信息

Carcinogenesis Division, National Cancer Center Research Institute, Tokyo.

出版信息

Jpn J Cancer Res. 1989 Dec;80(12):1149-52. doi: 10.1111/j.1349-7006.1989.tb01645.x.

DOI:10.1111/j.1349-7006.1989.tb01645.x
PMID:2516841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5917935/
Abstract

In a papillary thyroid carcinoma cell line, TPC-1, we found transcripts hybridizing to ret proto-oncogene (proto-ret) cDNA probes. The transcripts hybridized to the probes encoding the kinase domain but not to those of the transmembrane and extracellular domains of proto-ret. The sizes of the main transcripts in TPC-1 were aberrant, being 2.0, 2.5, 4.0 and 5.0 kb. In the neuroblastoma cell lines, the transcripts were 3.9, 4.5, 6.0 and 7.0 kb, which have been proved to be generated by alternative splicing and polyadenylation from the non-altered proto-ret oncogene. All of the four transcripts in TPC-1 are about 2 kb smaller than the corresponding ones in the neuroblastoma. From the length of the transcripts, it is suspected that the transcripts in TPC-1 are a rearranged form of proto-ret. This is the first report describing the aberrant transcripts of proto-ret in a human tumor.

摘要

在一种甲状腺乳头状癌细胞系TPC-1中,我们发现有转录本与原癌基因ret(proto-ret)的cDNA探针杂交。这些转录本与编码激酶结构域的探针杂交,但不与proto-ret跨膜和细胞外结构域的探针杂交。TPC-1中主要转录本的大小异常,分别为2.0、2.5、4.0和5.0 kb。在神经母细胞瘤细胞系中,转录本为3.9、4.5、6.0和7.0 kb,已证明这些转录本是由未改变的原癌基因ret通过可变剪接和聚腺苷酸化产生的。TPC-1中的所有四个转录本都比神经母细胞瘤中的相应转录本小约2 kb。从转录本的长度推测,TPC-1中的转录本是proto-ret的重排形式。这是首篇描述人类肿瘤中原癌基因ret异常转录本的报告。